Maternal serum analyte levels after first-trimester multifetal pregnancy reduction

L. P. Shulman, Owen Phillips, T. A. Cervetti

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

OBJECTIVE: Our purpose was to assess the effect of multifetal pregnancy reduction on maternal serum levels of analytes used for screening low-risk women for fetal chromosome abnormalities and neural tube defects. STUDY DESIGN: Peripheral blood samples were obtained between 15.0 and 20.9 weeks' gestation from 10 consecutive women who had undergone first-trimester multifetal pregnancy reduction. The samples were assayed for levels of α- fetoprotein, human chorionic gonadotropin, and unconjugated estriol. Analyte concentrations were interpreted within our maternal serum screening program. RESULTS: Levels of α-fetoprotein were significantly elevated in all samples. In each pregnancy levels of human chorionic gonadotropin and unconjugated estriol were consistent with the number of continuing gestations. CONCLUSIONS: First-trimester multifetal reduction does not alter second- trimester levels of human chorionic gonadotropin and unconjugated estriol. Further study is needed to determine whether these analytes could be used to screen pregnancies for fetal chromosome abnormalities after first-trimester multifetal reduction.

Original languageEnglish (US)
Pages (from-to)1072-1074
Number of pages3
JournalAmerican Journal of Obstetrics and Gynecology
Volume174
Issue number3
DOIs
StatePublished - Jan 1 1996

Fingerprint

Multifetal Pregnancy Reduction
First Pregnancy Trimester
Estriol
Chorionic Gonadotropin
Mothers
Fetal Proteins
Pregnancy
Serum
Chromosome Aberrations
Neural Tube Defects
Second Pregnancy Trimester

All Science Journal Classification (ASJC) codes

  • Obstetrics and Gynecology

Cite this

Maternal serum analyte levels after first-trimester multifetal pregnancy reduction. / Shulman, L. P.; Phillips, Owen; Cervetti, T. A.

In: American Journal of Obstetrics and Gynecology, Vol. 174, No. 3, 01.01.1996, p. 1072-1074.

Research output: Contribution to journalArticle

@article{8c347891ddf847ff901b08826901b7c8,
title = "Maternal serum analyte levels after first-trimester multifetal pregnancy reduction",
abstract = "OBJECTIVE: Our purpose was to assess the effect of multifetal pregnancy reduction on maternal serum levels of analytes used for screening low-risk women for fetal chromosome abnormalities and neural tube defects. STUDY DESIGN: Peripheral blood samples were obtained between 15.0 and 20.9 weeks' gestation from 10 consecutive women who had undergone first-trimester multifetal pregnancy reduction. The samples were assayed for levels of α- fetoprotein, human chorionic gonadotropin, and unconjugated estriol. Analyte concentrations were interpreted within our maternal serum screening program. RESULTS: Levels of α-fetoprotein were significantly elevated in all samples. In each pregnancy levels of human chorionic gonadotropin and unconjugated estriol were consistent with the number of continuing gestations. CONCLUSIONS: First-trimester multifetal reduction does not alter second- trimester levels of human chorionic gonadotropin and unconjugated estriol. Further study is needed to determine whether these analytes could be used to screen pregnancies for fetal chromosome abnormalities after first-trimester multifetal reduction.",
author = "Shulman, {L. P.} and Owen Phillips and Cervetti, {T. A.}",
year = "1996",
month = "1",
day = "1",
doi = "10.1016/S0002-9378(96)70353-8",
language = "English (US)",
volume = "174",
pages = "1072--1074",
journal = "American Journal of Obstetrics and Gynecology",
issn = "0002-9378",
publisher = "Mosby Inc.",
number = "3",

}

TY - JOUR

T1 - Maternal serum analyte levels after first-trimester multifetal pregnancy reduction

AU - Shulman, L. P.

AU - Phillips, Owen

AU - Cervetti, T. A.

PY - 1996/1/1

Y1 - 1996/1/1

N2 - OBJECTIVE: Our purpose was to assess the effect of multifetal pregnancy reduction on maternal serum levels of analytes used for screening low-risk women for fetal chromosome abnormalities and neural tube defects. STUDY DESIGN: Peripheral blood samples were obtained between 15.0 and 20.9 weeks' gestation from 10 consecutive women who had undergone first-trimester multifetal pregnancy reduction. The samples were assayed for levels of α- fetoprotein, human chorionic gonadotropin, and unconjugated estriol. Analyte concentrations were interpreted within our maternal serum screening program. RESULTS: Levels of α-fetoprotein were significantly elevated in all samples. In each pregnancy levels of human chorionic gonadotropin and unconjugated estriol were consistent with the number of continuing gestations. CONCLUSIONS: First-trimester multifetal reduction does not alter second- trimester levels of human chorionic gonadotropin and unconjugated estriol. Further study is needed to determine whether these analytes could be used to screen pregnancies for fetal chromosome abnormalities after first-trimester multifetal reduction.

AB - OBJECTIVE: Our purpose was to assess the effect of multifetal pregnancy reduction on maternal serum levels of analytes used for screening low-risk women for fetal chromosome abnormalities and neural tube defects. STUDY DESIGN: Peripheral blood samples were obtained between 15.0 and 20.9 weeks' gestation from 10 consecutive women who had undergone first-trimester multifetal pregnancy reduction. The samples were assayed for levels of α- fetoprotein, human chorionic gonadotropin, and unconjugated estriol. Analyte concentrations were interpreted within our maternal serum screening program. RESULTS: Levels of α-fetoprotein were significantly elevated in all samples. In each pregnancy levels of human chorionic gonadotropin and unconjugated estriol were consistent with the number of continuing gestations. CONCLUSIONS: First-trimester multifetal reduction does not alter second- trimester levels of human chorionic gonadotropin and unconjugated estriol. Further study is needed to determine whether these analytes could be used to screen pregnancies for fetal chromosome abnormalities after first-trimester multifetal reduction.

UR - http://www.scopus.com/inward/record.url?scp=0029880115&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029880115&partnerID=8YFLogxK

U2 - 10.1016/S0002-9378(96)70353-8

DO - 10.1016/S0002-9378(96)70353-8

M3 - Article

VL - 174

SP - 1072

EP - 1074

JO - American Journal of Obstetrics and Gynecology

JF - American Journal of Obstetrics and Gynecology

SN - 0002-9378

IS - 3

ER -